Psoriasis, Moderate to Severe

DBCOND0031872Immune System DiseasesSkin and Subcutaneous Tissue Diseases

Psoriasis, Moderate to Severe is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Moderate to Severe Psoriasis · Moderate-to-severe Psoriasis
Classified under
Indicated drugs

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Psoriasis, Moderate to Severe share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In